Abstract
AN apparent paradox prevents accurate assessment of the role of cyclic AMP in the development and maintenance of tumours. Although cell culture experiments indicate that malignant transformation is associated with decreased adenylate cyclase activity and intracellular cyclic AMP levels1,2, the same is not true of in vivo studies with tumours, in which a range of results have been obtained, from low3 to normal4 and elevated5 tumour cell cyclic AMP levels. We report here the development of a transplantable osteogenic sarcoma which has retained through many generations a parathyroid hormone-responsive adenylate cyclase, providing a system which can be used to evaluate the significance of hormone-responsive adenylate cyclase for tumour cell growth and differentiation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Sheppard, J. R., Nature new Biol., 236, 14–16 (1972).
Rein, A., Carchman, R. A., Johnson, G. S., and Pastan, I., Biochem. biophys. Res. Commun., 52, 899–904 (1973).
Allen, D. O., Munshower, J., Morris, H. P., and Weber, C., Cancer Res., 31, 557–560 (1971).
Boyd, H., Louis, C. J., and Martin, T. J., Cancer Res., 34, 1720–1725 (1974).
Chayoth, R., Epstein, S. M., and Field, J. B., Cancer Res., 33, 1970–1974 (1973).
Bensted, J. P. M., Blackett, N. M., and Lamerton, L. F., Br. J. Radiol., 34, 160–175 (1961).
Geddes-Dwyer, V., Bosanquet, J. S., O'Grady, R. L., and Cameron, D. A., Pathology, 6, 71–78 (1974).
Tregear, G. W., et al., Endocrinology, 93, 1349–1353 (1973).
Smith, D. M., and Johnston, C. C., Jr., Endocrinology, 95, 130–139 (1974).
Schorr, I., and Ney, R. L., J. clin. Invest., 50, 1295–1300 (1971).
Schorr, I., Rathnam, P., Saxena, B. B., and Ney, R. L., J. biol. Chem., 246, 5,806–5,811, (1971).
Goldfine, I. D., Roth, J., and Birnbaumer, L., J. biol., Chem., 247, 1,211–1,218, (1972).
Martin, T. J., et al., Clinical Endocrinology, 5, suppl. 373S–386S.
Christoffersen, T., Morland, J., Osnes, J. B., and Elgjo, K., Biochim. biophys. Acta, 279, 363–366 (1972).
Hartree, E. F., Analyt. Biochem., 48, 422–427 (1972).
Salomon, Y., Londos, C., and Rodbell, M., Analyt. Biochem., 58, 541–548 (1974).
Hunt, N. H., Martin, T. J., Michelangeli, V. P., and Eisman, J. A., J. Endocr. (in the press).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
MARTIN, T., INGLETON, P., UNDERWOOD, J. et al. Parathyroid hormone-responsive adenylate cyclase in induced transplantable osteogenic rat sarcoma. Nature 260, 436–438 (1976). https://doi.org/10.1038/260436a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/260436a0
This article is cited by
-
Research models and mesenchymal/epithelial plasticity of osteosarcoma
Cell & Bioscience (2021)
-
Knockdown of PTHR1 in osteosarcoma cells decreases invasion and growth and increases tumor differentiation in vivo
Oncogene (2015)
-
Genetically engineered mouse models and human osteosarcoma
Clinical Sarcoma Research (2012)
-
Effects of aluminum on the parathyroid hormone receptors of bone and kidney
Kidney International (1990)
-
Bone resorption by experimentally induced osteogenic tumor
Journal of Bone and Mineral Metabolism (1989)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
